Abbott Laboratories (ABT) Current Deferred Tax Assets (2009 - 2014)

Abbott Laboratories has disclosed Current Deferred Tax Assets across 6 years of filings, most recently posting $1.7 billion for Q4 2014.

• In Q4 2014, Current Deferred Tax Assets fell 32.56% year-over-year to $1.7 billion; the TTM figure through Dec 2014 stood at $1.7 billion (down 32.56% YoY), while the FY2014 annual figure was $1.7 billion, down 32.56% from the prior year.
• Current Deferred Tax Assets came in at $1.7 billion for Q4 2014 at Abbott Laboratories, down from $2.5 billion in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $3.1 billion in Q4 2010 to a low of $1.7 billion in Q4 2014.
• Average Current Deferred Tax Assets over 5 years is $2.6 billion, with a median of $2.7 billion recorded in 2011.
• Year-over-year, Current Deferred Tax Assets soared 30.11% in 2010 and plunged 32.56% in 2014.
• Over 5 years, Current Deferred Tax Assets stood at $3.1 billion in 2010, then dropped by 12.19% to $2.7 billion in 2011, then climbed by 10.55% to $3.0 billion in 2012, then dropped by 15.34% to $2.5 billion in 2013, then sank by 32.56% to $1.7 billion in 2014.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $1.7 billion in Q4 2014, $2.5 billion in Q4 2013, and $3.0 billion in Q4 2012.